Real-time enrollment status for this advanced or metastatic solid tumor clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:35 AM UTC
| NCT Number | NCT04617522 |
| Recruiting Status | Recruiting |
| Condition | Advanced or Metastatic Solid Tumor |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 13, 2026: Clinical trial NCT04617522 is currently recruiting participants. This clinical trial study for advanced or metastatic solid tumor is actively seeking new participants at 8 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04617522 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04617522 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.